Serum microRNA-126 and -223 as new-generation biomarkers for sarcoidosis in patients with heart failure.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of cardiology"
DOI: 10.1016/j.jjcc.2018.06.004
Abstract: BACKGROUND Although cardiac sarcoidosis is associated with poor prognosis, diagnosis of the disease is challenging and the sensitivity and specificity of diagnostic modalities are limited. This study was performed to evaluate the potential of serum… read more here.
Keywords: new generation; patients cardiac; generation biomarkers; sarcoidosis ... See more keywords